Sodium Bicarbonate Ringer's Solution Versus Normal Saline for Early Fluid Resuscitation in Patients With Sepsis
Launched by XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY · Nov 5, 2020
Trial Information
Current as of July 21, 2025
Unknown status
Keywords
ClinConnect Summary
Sepsis and septic shock are clinical emergencies requiring immediate treatment and fluid resuscitation. Early effective fluid resuscitation can improve the prognosis of patients. So far, there is no perfect crystalloid solution. Normal saline is the most readily available and economical crystalline fluid for clinical resuscitation. It is isoosmotic and can meet the basic needs of patients in the early rehydration. But it lacks acid-base buffer system and potassium, calcium and magnesium ions, and the level of chloride ions is also significantly higher than that of plasma.
Sodium Bicarbonat...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed as sepsis or septic shock according to the definition of Sepsis-3.0 with fluid resuscitation requirement;
- • aged between 18 and 80, male or female;
- • Signed informed Consent (with delay within 24 hours).
- Exclusion Criteria:
- • Patients with hypermagnesemia;
- • Patients with hypothyroidism;
- • Patients predicted to die or discharged within 24 hours after admission;
- • Patients with previous history of mental illness, severe hepatic and renal insufficiency, severe cardiac disease, primary severe central nervous system lesions;
- • Pregnant or breast-feeding women;
- • Patients who have received cardiopulmonary resuscitation;
- • Patients who participated in other clinical trials within 30 days;
- • Patients have other conditions that are not appropriate for inclusion according to the researcher's judgment.
About Xiangya Hospital Of Central South University
Xiangya Hospital of Central South University is a leading academic medical institution located in Changsha, China, renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a key affiliate of Central South University, the hospital integrates clinical practice with medical education and research, fostering an environment that promotes the development of cutting-edge therapies and treatments. With a diverse array of specialized departments and a dedicated team of healthcare professionals, Xiangya Hospital actively participates in clinical trials aimed at enhancing medical knowledge and improving patient outcomes, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Changsha, Hunan, China
Patients applied
Trial Officials
Lina Zhang
Principal Investigator
Xiangya Hospital of Central South University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials